Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Return on Sales (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Return on Sales for 13 consecutive years, with 723.2% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 112835.0% year-over-year to 723.2%, compared with a TTM value of 17.68% through Dec 2025, down 736.0%, and an annual FY2025 reading of 263.6%, down 25328.0% over the prior year.
  • Return on Sales was 723.2% for Q4 2025 at Abvc Biopharma, up from 1.62% in the prior quarter.
  • Across five years, Return on Sales topped out at 723.2% in Q4 2025 and bottomed at 2429.6% in Q1 2024.
  • Average Return on Sales over 5 years is 161.2%, with a median of 11.87% recorded in 2023.
  • The sharpest move saw Return on Sales plummeted -241481bps in 2024, then soared 243362bps in 2025.
  • Year by year, Return on Sales stood at 182.61% in 2021, then crashed by -104bps to 7.64% in 2022, then tumbled by -3434bps to 270.04% in 2023, then tumbled by -50bps to 405.15% in 2024, then soared by 279bps to 723.2% in 2025.
  • Business Quant data shows Return on Sales for ABVC at 723.2% in Q4 2025, 1.62% in Q3 2025, and 17.84% in Q2 2025.